• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Mental Wellness App Use, Adoption Hasn’t Spiked During COVID-19

Share:

July 2, 2020

Mental health and wellness app use has been on the rise during the past few months of COVID-19, but new quarantines and disease concerns may not be fueling the spike in new users or other metrics.

According to a recent data report from Apptopia, increases among the 15 most popular of these apps have been in lockstep with the gradual trend of rising engagement that the mobile app market-intelligence group has been monitoring for the last three years.

“Reflective of the market as a whole, most of the apps we analyzed were largely unaffected by the pandemic, continuing to grow or decline according to their previous trend line,” Apptopia’s Madeline Lenahan wrote in a blog post describing the market data.

“For instance, Calm, the largest app of the group, may look like it’s surging in recent months: New installs of the app were 18% higher in May than January, and app sessions were 23% higher. And on June 14, Calm achieved its highest [daily active users] in its lifetime with approximately 4.6 million. Still, this record high engagement does not deviate from the app’s trend line,” she wrote.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Looking at the month of May, Apptopia observed a 66% YoY increase in total mental wellness app sessions – although Lenahan wrote that this could be misleading due to an “abnormally poor” performance in May of last year. More drastic is a 4% YoY decline in net new installs – a metric for gauging new users – following year after year of steady increases.

“This means it’s loyal users, not new users who are driving the strong engagement lately,” she wrote.

WHY IT MATTERS

The in-line trend-finding doesn’t discount substantial use of the top mental health apps during quarantine, Lenahan wrote. From March to May, Calm logged roughly 350 million sessions, while Headspace, the second most-used, came in at around 150 million sessions.

However, the steady trends here are at odds with the broader discussion of increased digital health and telehealth adoption during the pandemic, particularly in terms of mental health. For these products, rather than enjoying a major leap, these companies may have to settle for slow and steady market growth.

“While mental wellness apps are growing in popularity, their success is not directly tied to the pandemic,” Lenahan wrote. “This, of course, is not a bad thing, as the high engagement we’re seeing is a signal that these apps have loyal users. I expect this market to continue to grow and expand as more people embrace telehealth in all of its forms.”

THE LARGER TREND

From consumer apps to telehealth to digital health programs, many in the industry have highlighted a growing demand for mental healthcare and the potential for scalable technologies to address those needs. Both Headspace and Big Health have recently seen interest from investors and announced major funding rounds, while others such as Omada and Hims began offering mental health components of their platforms for free during the COVID-19 emergency.

Source: MobiHealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Philips Unveils Vendor-Neutral Radiology Operations Command Center, Automated Radiology Workflow SuitePhilips Unveils Vendor-Neutral Radiology Operations Command Center, Automated Radiology Workflow Suite
  • Research: October Health It M&a Activity, Public Company PerformanceResearch: October Health It M&a Activity, Public Company Performance
  • Dementia Discovery Fund reels in $350M for disease-modifying drugsDementia Discovery Fund reels in $350M for disease-modifying drugs
  • Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to Over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research
  • CLEAR’s COVID-19 Verification Pass Will Now Integrate with Apple HealthCLEAR’s COVID-19 Verification Pass Will Now Integrate with Apple Health
  • Kidney Care Startup Strive Lands $140M in Alphabet Led RoundKidney Care Startup Strive Lands $140M in Alphabet Led Round
  • Traditions Health Expands Presence in Arizona; Acquires Pathways HospiceTraditions Health Expands Presence in Arizona; Acquires Pathways Hospice
  • Veranex Announces Acquisition of IMMRVeranex Announces Acquisition of IMMR

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications